Elmind Capital, LP
Elmind Capital, LP reported 30 holdings worth US$404M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Elmind Capital, LP reported 30 holdings worth US$404M as of Sep 30, 2026. Largest: Celldex Therapeutics, Inc., Legend Biotech Corp. and Syndax Pharmaceuticals, Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 30
- Value as reported
- US$404M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Celldex Therapeutics, Inc. | 1.11M | US$36M | 8.9% |
| Legend Biotech Corp. | 1.57M | US$31.2M | 7.7% |
| Syndax Pharmaceuticals, Inc. | 1.6M | US$30.2M | 7.5% |
| Cogent Biosciences, Inc. | 867K | US$27.8M | 6.9% |
| Relay Therapeutics, Inc. | 1.47M | US$26.4M | 6.5% |
| Amylyx Pharmaceuticals, Inc. | 895K | US$26M | 6.4% |
| Viridian Therapeutics, Inc. | 1.22M | US$25.2M | 6.2% |
| Vaxcyte, Inc. | 372K | US$21.2M | 5.2% |
| Travere Therapeutics, Inc. | 323K | US$19M | 4.7% |
| Cullinan Therapeutics, Inc. | 963K | US$14.8M | 3.7% |
| Vera Therapeutics, Inc. | 437K | US$14.1M | 3.5% |
| CytomX Therapeutics, Inc. | 4.55M | US$12.4M | 3.1% |
| Beam Therapeutics Inc. | 476K | US$11.6M | 2.9% |
| Nurix Therapeutics, Inc. | 460K | US$10.9M | 2.7% |
| Summit Therapeutics Inc. | 494K | US$8.35M | 2.1% |
| United Therapeutics Corporation | 15,000 | US$8.13M | 2.0% |
| Immunocore Holdings plc | 256K | US$7.76M | 1.9% |
| Krystal Biotech, Inc. | 22,000 | US$7.32M | 1.8% |
| Alumis Inc. | 750K | US$5.54M | 1.4% |
| BioCryst Pharmaceuticals, Inc. | 520K | US$4.33M | 1.1% |
| Sutro Biopharma, Inc. | 228K | US$3.68M | 0.91% |
| MBX Biosciences, Inc. | 61,000 | US$3.58M | 0.89% |
| DBV Technologies SA | 265K | US$3.12M | 0.77% |
| Supernus Pharmaceuticals, Inc. | 70,000 | US$3.01M | 0.75% |
| BioMarin Pharmaceutical Inc. | 47,000 | US$2.82M | 0.70% |
| Septerna, Inc. | 49,444 | US$1.93M | 0.48% |
| Alector, Inc. | 916K | US$1.69M | 0.42% |
| Design Therapeutics, Inc. | 108K | US$1.36M | 0.34% |
| Insmed Incorporated | 0 | US$0 | 0.00% |
| Protagonist Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Tyra Biosciences, Inc. | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC
Related